Featured image: Invokana and Fournier's Gangrene

Invokana and Fournier’s Gangrene: Rare Yet Serious Infection

In 2018, the U.S. Food and Drug Administration (FDA) warned physicians about the risk of genital infection in diabetic patients who are treated with SGLT2 inhibitors. Medications under this class of drugs stop your kidneys from reabsorbing glucose back into your blood. This allows your kidneys to remove sugar from your body through the urine. […]


Featured image: Invokana amputation

Invokana and Amputation Risks: All You Need to Know

When Invokana was approved in 2013, it was seen as a breakthrough treatment for type 2 diabetes patients. After it hit the market, however, it caused unexpected side effects that were not mentioned on its warning label. This resulted in thousands of people filing an Invokana lawsuit against the drug’s manufacturer. According to plaintiffs, they […]